Schedule

• Monday 31st October 2022

   

  Monday 31st October	Poster Session A	11:00 AM - 12:45 PM US PDT
  Jesujuwonlo Fadipe	Facilitators of, and barriers to, fully integrating seasonal malaria chemoprevention with vitamin A supplementation: A qualitative enquiry
  Monica De Cola	Measuring the impact of seasonal malaria chemoprevention on malaria prevalence and incidence using routine data
  Ann-Sophie Stratil	Optimising the delivery of routine malaria data quality assessments in Mozambique
  Ekechi Okereke	Optimising the role of lead mothers in seasonal malaria chemoprevention (SMC) campaigns: insights from formative research in Kano State, Northern Nigeria
  Dawit Getachew	Performance of Community Health Influencers, Promoters and Services (CHIPS) on case management of uncomplicated malaria
  Narcisse Tounaikok	The results of a role model study to explore the administration of SPAQ during SMC in children aged 3 to 59 months in Chad
  Cheick Compaore	Using the role model approach to identify best practices and challenges during seasonal malaria chemoprevention drug administration in Burkina Faso

   

• Tuesday 1st November 2022

   

  Tuesday 1st November	Poster Session B	12:00 PM - 1:45 PM US PDT
  Michael Ekholuenetal	Assessing Nigerian caregivers’ health-seeking behaviour when managing febrile illness and malaria in infants
  Ann-Sophie Stratil	Contributing to malaria elimination: Lessons from delivering Plasmodium vivax malaria radical cure in northern Cambodia
  Semiu Rahman	Cultural factors influencing the implementation of perennial malaria chemoprevention in children under five, Nigeria
  Olusola Oresanya	Harnessing the seasonal malaria chemoprevention campaign in Nigeria: Safety, equity and cost of fully integrating vitamin A supplementation
  Narcisse Tounaikok	Feasibility and acceptability of extending seasonal malaria chemoprevention to children aged 5–10 years in Chad
  Taiwo Ibinaiye	Impact assessment of seasonal malaria chemoprevention in Kogi state using Routine Health Management Information System (HMIS) surveillance data
  Maureen Nakirunda, Erica Viganò	Integrating gender into the process evaluation of seasonal malaria chemoprevention in Karamoja, Uganda: results and future directions

   

• Wednesday 2nd November 2022

   

  Wednesday 2nd November	Symposium Live	08:00 AM - 09:45 AM US PDT
  Kevin Baker	Implementing seasonal malaria chemoprevention in new geographies outside the Sahel
  Wednesday 2nd November	Oral presentation Live stream	09:15 AM - 09:30 AM US PDT
  Chinazo Ujuju	Assessment of baseline molecular markers of sulfadoxine-pyrimethamine resistance in Ebonyi and Osun states, Nigeria: Toward implementation of perennial malaria chemoprevention.
  Wednesday 2nd November	Poster session C	11:00 AM - 12:45 PM US PDT
  Mercia Sitoe	Acceptability of seasonal malaria chemoprevention among children under five in Mozambique: A qualitative study
  Musa Odongo	Assessing the quality of SMC delivery by village health teams in Uganda
  David Salandini Odong	Evaluating the adaptation of seasonal malaria chemoprevention implementation during COVID-19 in Karamoja, Uganda
  Wednesday 2nd November	Oral presentation live	4:15 PM - 4:30 PM US PDT
  Anthony Nuwa	A cross-sectional survey to assess the feasibility and acceptability of seasonal malaria chemoprevention among nomadic pastoralist population; The case of Karamoja, region in Uganda.

   

• Thursday 3rd November 2022

   

  Thursday 3rd November	Symposium Live	08:00 AM - 09:45 AM US PDT
  Kevin Baker	Defining and acting on pneumonia research priorities – from evidence to impact: Results from an eDelphi research priority setting exercise (08:10 AM - 08:30 AM)
  Thursday 3rd November	Oral presentation Live	08:15 AM - 08:30 AM US PDT
  Anthony Nuwa	A non-randomised controlled trial to assess the protective effect of Seasonal Malaria Chemoprevention in the context of high parasite resistance in Uganda.